Preoperative physiological data and lung cancer surgery: do the same factors predict post-operative morbidity/mortality and long term survival? Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005
Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019
Prediction of long-term effect of anti-angiogenic therapy in lung cancer patients by monitoring early changes in circulating-tumor DNA (ctDNA). Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020
First hospitalization in lung cancer patients – is timing important? Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
Long-term survival in lung cancer after surgery: is gender a prognostic factor? Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer? Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk? Source: Eur Respir J, 58 (1) 2100342; 10.1183/13993003.00342-2021 Year: 2021
Are biphosphonates efficient in the adjuvant treatment of lung cancer? Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006
Evaluation of causes and characteristics of lung cancer mortality Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005
Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Does the incorporation of new generation cytotoxic agent improve the overall outcome in inoperable nonsmall cell lung cancer (NSCLC)? Source: Eur Respir J 2003; 22: Suppl. 45, 64s Year: 2003
Optimising treatment for post-operative lung cancer recurrence Source: Eur Respir J 2016; 47: 374-378 Year: 2016
Lung clearance index for evaluation of late complications of cancer therapy in children Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019
Metformin improves survival in lung cancer patients receiving EGFR-TKIs therapy> Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019